• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EGCG 抑制 STAT3 信号通路的机制。

Mechanism of the inhibition of the STAT3 signaling pathway by EGCG.

机构信息

Huaihe Hospital, Henan University, Kaifeng 475000, P.R. China.

出版信息

Oncol Rep. 2013 Dec;30(6):2691-6. doi: 10.3892/or.2013.2743. Epub 2013 Sep 20.

DOI:10.3892/or.2013.2743
PMID:24065300
Abstract

Signal transducer and activator of transcription 3 (STAT3) is an oncogene that promotes cell survival, proliferation, and motility. In the present study, we explored the mechanism involved in the inhibition by epigallocatechin-3-gallate (EGCG) of STAT3 signaling as detected by surface plasmon resonance (SPR)-binding assays and in silico docking. Stat3‑binding assay indicated that EGCG significantly interrupted Stat3 peptide binding at micromolar concentrations, and the docking experiments indicated that EGCG had a strong interaction with Arg-609, one of the key residues in the STAT3 SH2 domain that contributes greatly to Stat3 and phosphorylated peptide binding. Following treatment of the hepatocellular carcinoma cell lines BEL-7402 and QGY-7703 with EGCG, in vitro, EGCG significantly suppressed cell proliferation as detected by MTT assay, induced apoptosis as detected by flow cytometry, dramatically lowered the expression levels of phosphorylated Stat3 proteins (p-Stat3) as determined by immunoblot detection, and inhibited the expression of multiple genes including Bcl-xL, c-Myc, VEGF and cyclin D1 as demonstrated by RT-PCR analysis. In conclusion, our research data indicate that the anticancer function of green tea results from the inhibition of the STAT3 signaling pathway by EGCG.

摘要

信号转导子和转录激活因子 3(STAT3)是一种致癌基因,可促进细胞存活、增殖和迁移。在本研究中,我们通过表面等离子体共振(SPR)结合分析和计算机对接实验探索了 EGCG 抑制 STAT3 信号通路的机制。Stat3 结合实验表明,EGCG 在微摩尔浓度下可显著中断 Stat3 肽的结合,对接实验表明,EGCG 与 STAT3 SH2 结构域中的关键残基之一 Arg-609 具有很强的相互作用,Arg-609 对 Stat3 和磷酸化肽的结合有很大贡献。在体外使用 EGCG 处理肝癌细胞系 BEL-7402 和 QGY-7703 后,MTT 检测表明 EGCG 显著抑制细胞增殖,流式细胞术检测表明诱导细胞凋亡,免疫印迹检测表明磷酸化 Stat3 蛋白(p-Stat3)的表达水平显著降低,RT-PCR 分析表明多种基因的表达受到抑制,包括 Bcl-xL、c-Myc、VEGF 和 cyclin D1。综上所述,我们的研究数据表明,绿茶的抗癌功能源自 EGCG 抑制 STAT3 信号通路。

相似文献

1
Mechanism of the inhibition of the STAT3 signaling pathway by EGCG.EGCG 抑制 STAT3 信号通路的机制。
Oncol Rep. 2013 Dec;30(6):2691-6. doi: 10.3892/or.2013.2743. Epub 2013 Sep 20.
2
Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.绿茶多酚表没食子儿茶素-3-没食子酸酯通过抑制信号转导和转录激活因子3(STAT3)信号通路来抑制瘢痕疙瘩成纤维细胞中的胶原蛋白生成和增殖。
J Invest Dermatol. 2008 Oct;128(10):2429-41. doi: 10.1038/jid.2008.103. Epub 2008 May 8.
3
[(-)-Epigallocatechin-3-gallate reduces vascular endothelial growth factor expression in gastric cancer cells via suppressing activity].(-)-表没食子儿茶素-3-没食子酸酯通过抑制活性降低胃癌细胞中血管内皮生长因子的表达
Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Aug;14(8):631-5.
4
Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.表没食子儿茶素没食子酸酯通过抑制 AKT 通路抑制肝癌细胞生长,诱导细胞凋亡,并导致 S 期阻滞。
Int J Oncol. 2014 Mar;44(3):791-6. doi: 10.3892/ijo.2014.2251. Epub 2014 Jan 8.
5
The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.绿茶成分(-)-表没食子儿茶素-3-没食子酸酯可下调N-钙黏蛋白并抑制膀胱癌细胞的迁移。
J Cell Biochem. 2007 Oct 1;102(2):377-88. doi: 10.1002/jcb.21299.
6
Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.表没食子儿茶素-3-没食子酸酯对人头颈鳞状细胞癌细胞系生长、表皮生长因子受体信号通路、基因表达及化疗敏感性的影响
Clin Cancer Res. 2001 Dec;7(12):4220-9.
7
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.表没食子儿茶素-3-没食子酸酯抑制人头颈部和乳腺癌细胞中HER-2/neu的激活及下游信号通路。
Clin Cancer Res. 2003 Aug 15;9(9):3486-91.
8
Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.表没食子儿茶素没食子酸酯通过刺激AKT/STAT3信号通路和抑制多药耐药1信号,使顺铂耐药的口腔癌CAR细胞对凋亡和自噬敏感。
Environ Toxicol. 2017 Mar;32(3):845-855. doi: 10.1002/tox.22284. Epub 2016 May 20.
9
Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.氯化两面针碱通过抑制 JAK1/STAT3 信号通路抑制肝癌细胞体内生长。
Int J Mol Med. 2013 Jul;32(1):79-84. doi: 10.3892/ijmm.2013.1358. Epub 2013 Apr 22.
10
A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.一种绿茶多酚,表没食子儿茶素没食子酸酯,可能通过抑制Bcl-2家族蛋白诱导人肝癌细胞凋亡。
J Hepatol. 2006 Jun;44(6):1074-82. doi: 10.1016/j.jhep.2005.11.045. Epub 2005 Dec 28.

引用本文的文献

1
Ultrahigh-Throughput Virtual Screening Strategies against PPI Targets: A Case Study of STAT Inhibitors.针对蛋白质-蛋白质相互作用靶点的超高通量虚拟筛选策略:以STAT抑制剂为例
J Chem Inf Model. 2025 Jul 28;65(14):7734-7748. doi: 10.1021/acs.jcim.5c00907. Epub 2025 Jul 4.
2
Extracts from Target STAT3 Signaling Pathway to Overcome Cisplatin Resistance in Lung Cancer.提取靶向信号转导和转录激活因子3信号通路以克服肺癌顺铂耐药性。
Mar Drugs. 2025 Apr 14;23(4):167. doi: 10.3390/md23040167.
3
Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy.
天然化合物作为蛋白酶抑制剂在癌症治疗治疗中的应用。
Anticancer Agents Med Chem. 2024;24(16):1167-1181. doi: 10.2174/0118715206303964240708095110.
4
Label-free biomolecular and cellular methods in small molecule epigallocatechin-gallate research.小分子表没食子儿茶素没食子酸酯研究中的无标记生物分子和细胞方法。
Heliyon. 2024 Feb 5;10(3):e25603. doi: 10.1016/j.heliyon.2024.e25603. eCollection 2024 Feb 15.
5
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.没食子儿茶素没食子酸酯在肿瘤微环境、代谢重编程和免疫治疗中的作用。
Front Immunol. 2024 Jan 29;15:1331641. doi: 10.3389/fimmu.2024.1331641. eCollection 2024.
6
A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells.HPV 阳性 ME180 和 HPV 阴性 C33A 宫颈癌细胞中 EGFR 结合、活力和迁移的植物成分比较分析。
Med Oncol. 2023 Nov 14;40(12):357. doi: 10.1007/s12032-023-02223-2.
7
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications.没食子酸表没食子儿茶素酯在癌症治疗中的潜力:作用机制与临床意义。
Molecules. 2023 Jul 6;28(13):5246. doi: 10.3390/molecules28135246.
8
The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma.表没食子儿没食子酸酯在肝细胞癌化学预防和治疗中的潜力。
Front Pharmacol. 2023 May 24;14:1201085. doi: 10.3389/fphar.2023.1201085. eCollection 2023.
9
The function of natural compounds in important anticancer mechanisms.天然化合物在重要抗癌机制中的作用。
Front Oncol. 2023 Jan 4;12:1049888. doi: 10.3389/fonc.2022.1049888. eCollection 2022.
10
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3--gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.绿茶儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的治疗潜力:与宿主/病毒蛋白酶的主要相互作用
Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30.